However, loss of MHC class I in DFT1 is reversible upon treatment with the inflammatory cytokine IFNγ (Siddle et al., 2013) and a small number of individuals have been found to have a successful immune response against the tumour (Pye et al., 2016a). This evidence concerns the gene IFNG and neoplasm.